This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ciornei, C. D. Articles by Bodelsson, M. Search for Related Content PubMed PubMed Citation Articles by Ciornei, C. D. Articles by Bodelsson, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2005, p. 2845-2850, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.2845-2850.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Antimicrobial and Chemoattractant Activity, Lipopolysaccharide Neutralization, Cytotoxicity, and Inhibition by Serum of Analogs of Human Cathelicidin LL-37

Cristina D. Ciornei,^1, Thorgerdur Sigurdardóttir,¹ Artur Schmidtchen,² and Mikael Bodelsson^1*

Department of Anesthesiology and Intensive Care,¹ Department of Dermatology and Venereology, Lund University, Lund, Sweden²

Received 16 December 2004/ Returned for modification 13 January 2005/ Accepted 3 April 2005

Antimicrobial peptides have been evaluated in vitro and in vivo as alternatives to conventional antibiotics. Apart from being antimicrobial, the native human cathelicidin-derived peptide LL-37 (amino acids [aa] 104 to 140 of the human cathelicidin antimicrobial peptide) also binds and neutralizes bacterial lipopolysaccharide (LPS) and might therefore have beneficial effects in the treatment of septic shock. However, clinical trials have been hampered by indications of toxic effects of LL-37 on mammalian cells and evidence that its antimicrobial effects are inhibited by serum. For the present study, LL-37 was compared to two less hydrophobic fragments obtained by N-terminal truncation, named 106 (aa 106 to 140) and 110 (aa 110 to 140), and to a previously described more hydrophobic variant, the 18-mer LLKKK, concerning antimicrobial properties, lipopolysaccharide neutralization, toxicity against human erythrocytes and cultured vascular smooth muscle cells, chemotactic activity, and inhibition by serum. LL-37, fragments 106 and 110, and the 18-mer LLKKK inhibited the growth of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans in a radial diffusion assay, inhibited lipopolysaccharide-induced vascular nitric oxide production, and attracted neutrophil granulocytes similarly. While fragments 106 and 110 caused less hemolysis and DNA fragmentation in cultured cells than did LL-37, the 18-mer LLKKK induced severe hemolysis. The antibacterial effect of fragments 106 and 110 was not affected by serum, while the effect of LL-37 was reduced. We concluded that the removal of N-terminal hydrophobic amino acids from LL-37 decreases its cytotoxicity as well as its inhibition by serum without negatively affecting its antimicrobial or LPS-neutralizing action. Such LL-37-derived peptides may thus be beneficial for the treatment of patients with sepsis.

Present address: Department of Surgery, Malmö University Hospital, Malmö, Sweden.

This article has been cited by other articles:

• Bu, H.-F., Wang, X., Zhu, Y.-Q., Williams, R. Y., Hsueh, W., Zheng, X., Rozenfeld, R. A., Zuo, X.-L., Tan, X.-D. (2006). Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity. J. Immunol. 177: 8767-8776 [Abstract] [Full Text]  
• Mookherjee, N., Wilson, H. L., Doria, S., Popowych, Y., Falsafi, R., Yu, J., Li, Y., Veatch, S., Roche, F. M., Brown, K. L., Brinkman, F. S. L., Hokamp, K., Potter, A., Babiuk, L. A., Griebel, P. J., Hancock, R. E. W. (2006). Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J. Leukoc. Biol. 80: 1563-1574 [Abstract] [Full Text]  
• Andra, J., Gutsmann, T., Garidel, P., Brandenburg, K. (2006). Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds. Innate Immunity 12: 261-277 [Abstract]  
• Sigurdardottir, T., Andersson, P., Davoudi, M., Malmsten, M., Schmidtchen, A., Bodelsson, M. (2006). In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37.. Antimicrob. Agents Chemother. 50: 2983-2989 [Abstract] [Full Text]  
• Motzkus, D., Schulz-Maronde, S., Heitland, A., Schulz, A., Forssmann, W.-G., Jubner, M., Maronde, E. (2006). The novel {beta}-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J. 20: 1701-1702 [Abstract] [Full Text]  
• Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., Ausubel, F. M. (2006). From the Cover: Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. USA 103: 10414-10419 [Abstract] [Full Text]  
• Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Orlando, F., Silvestri, C., Bozzi, A., Di Giulio, A., Luzi, C., Mangoni, M. L., Barra, D., Saba, V., Scalise, G., Rinaldi, A. C. (2006). Interaction of antimicrobial Peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.. Antimicrob. Agents Chemother. 50: 2478-2486 [Abstract] [Full Text]  
• Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., Powers, J.-P., Bryan, J., Brinkman, F. S. L., Hancock, R. E. W. (2006). Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37. J. Immunol. 176: 2455-2464 [Abstract] [Full Text]